Testing laboratory · Reviewed 2026-09-03
MZ Biolabs · Tucson, Arizona, USA
Legitimacy review
MZ Biolabs is a legitimate, established Arizona analytical company with named technical staff, a six-year entity trail, detailed instrumentation, and recurring peptide reports. It lacks a confirmed ISO/IEC 17025 scope and does not provide an issuer-controlled public report lookup.
MZ Biolabs LLC is an Arizona entity formed October 14, 2019. It lists 2102 N Country Club Rd, Suite C, Tucson, Arizona and names Ken Pendarvis as owner and analytical chemist, with Jaishree Mali, Jamie Young, and Armida Valencia in scientific and facility roles. Older certificates show a prior Tucson address, consistent with a later move.
Six-year state entity trail, named owner and scientific team, fixed laboratory address, detailed instrument disclosure, relevant scientific publication history, and recurring completed reports.
No ISO/IEC 17025 certificate and scope was found. The site's DEA Schedule III facility statement was not independently confirmed in this pass.
The COA service covers peptide and small-molecule purity, identity, and quantity across powders and finished formats. MZ clearly states that purity does not establish activity, sterility, endotoxin, metals, or pH.
Customer discussions include successful repeat use and roughly week-long results alongside communication complaints and individual document-quality questions. Aggregator counts establish broad use, not analytical accuracy.
No formal accreditation, current price list, public turnaround commitment, or issuer-controlled public record lookup was confirmed. Contact-only verification reduces public reproducibility but is not evidence that a report is invalid.
MZ Biolabs LLC has an Arizona entity trail beginning October 14, 2019. The current site identifies Ken Pendarvis as owner and analytical chemist and names additional analytical, microbiology, and facility staff. Pendarvis also appears as a coauthor on a 2009 mass-spectrometry paper, providing independently published technical-history evidence.
Current materials list 2102 N Country Club Rd, Suite C, Tucson. A 2024 certificate used the earlier 1635 E 18th St address, indicating a facility move rather than two current laboratory locations. The operation was co-founded with Nina Ossanna, while current materials identify Pendarvis as owner; the timing of that ownership transition was not established from a primary filing in this review.
MZ describes HPLC-UV or UPLC for purity and mass spectrometry for identity, and publishes unusually specific instrument information including Bruker Compact QTOF systems, a Thermo LTQ Velos Pro, and Waters nanoAcquity and Acquity UPLC equipment. Its own guidance correctly separates purity from activity, sterility, endotoxin, metals, and pH.
A 2024 interview described roughly 12-to-14-minute UPLC runs, multi-page certificates, and raw mass-spectrometry material. Other numerical statements in that vendor-produced interview—including an anecdotal estimate about mislabeled samples—were not supported by a published denominator and should not be treated as market prevalence.
No current A2LA, PJLA, ANAB, or other ISO/IEC 17025 certificate and scope was located for MZ. A site statement about Schedule III authorization is a different regulatory concept and was not independently confirmed in this pass.
MZ does not expose an issuer-controlled public report search comparable with Janoshik, Freedom, or Kovera. Verification is contact-only and should include the client, compound, lot or batch, report date, and other printed identifiers. A lack of a public result is therefore not a no-match and must not be presented as evidence of invalidity.
Reviewed third-party-hosted examples include a March 2026 tirzepatide report showing 99.93% purity and an observed mass closely matching the expected value, and a September 2025 retatrutide report showing 99.67% purity with identity data. These documents show recurring issuance and detailed analytical output; because they are not served by an MZ public verifier, the issuer relationship remains contact-verifiable rather than independently reproducible online.
FDA advisory materials reproduce some MZ certificates as evidence submitted into a regulatory review, but inclusion is not an FDA endorsement of the laboratory. Community reports about a corrected chemical-name template and an endotoxin comparison lacking a common lot number are useful quality-control and custody cautions, not proof that the underlying analytical measurements were wrong.
COA verification
Open the exact MZ QR destination when a certificateId is present; otherwise use the authenticated client account or direct issuer confirmation.
Result handling
Use only when the official destination returns the same identifier and the material certificate fields agree.
Use only after a functioning official lookup explicitly returns no record for the submitted identifier.
Use when the official destination resolves the identifier but returns a different report, product, batch, or other material identity field.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
MZ remains reference-only for reports without an exact public certificateId; client-login or contact evidence must be captured before promotion.
Use when the issuer identity, required identifier, or official workflow cannot be established from the available evidence.
Certificate structure
Retain and display every page. MZ reports in the corpus range from 1 to 10 pages and average more than four pages.
Keep purity, mass-spectrometry identity, quantification, and add-on panels separate. Explicitly label sterility, endotoxin, heavy metals, or pH as absent unless the report contains those tests.
Evidence boundaries
Review receipts
Public search record
Search results include longstanding Reddit recommendations and criticism, vendor-hosted PDFs, and aggregator comparisons, but there is no open universal lookup surfaced. A useful review should focus on service scope and the difference between exact QR records and account/contact-only verification.
Sources
Reusable integration rule: For future vendors, extract the exact QR certificateId when present, preserve every page, and otherwise label the route account/contact-only rather than inventing a public lookup.
Frequently asked questions
Yes. MZ Biolabs is a legitimate, established Arizona analytical company with named technical staff, a six-year entity trail, detailed instrumentation, and recurring peptide reports. It lacks a confirmed ISO/IEC 17025 scope and does not provide an issuer-controlled public report lookup.
The COA service covers peptide and small-molecule purity, identity, and quantity across powders and finished formats. MZ clearly states that purity does not establish activity, sterility, endotoxin, metals, or pH.
No ISO/IEC 17025 accreditation confirmed. No ISO/IEC 17025 certificate and scope was found. The site's DEA Schedule III facility statement was not independently confirmed in this pass.
Open the exact MZ QR destination when a certificateId is present; otherwise use the authenticated client account or direct issuer confirmation.
The reviewed sources did not establish that vendors can purchase a passing result from MZ Biolabs. That is not an audited independence guarantee: sample selection, who pays, publication rights, blind-testing controls, and correction history still matter.
Physical-vial custody is unknown unless a documented chain connects the tested sample to the specific vial in hand.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Check the document
